ANDROGRAPHOLIDE DERIVATIVES FOR USE IN THE TREATMENT OF COVID-19 DISEASE AND PULMONARY FIBROSIS ASSOCIATED WITH COVID-19

Patent number:

No items found.

Disclosed are andrographolide derivatives for use as an antiviral agent in the treatment of COVID-19 disease or pulmonary fibrosis associated with COVID-19.

Countries:

Spain

Regions:

Valencian Community

Navarre

Centers:

CSIC, UNIVERSITAT DE VALENCIA, FUNDACION PARA LA INVESTIG MEDICA APLICADA, UNIVERSIDAD PUBLICA DE NAVARRA, UNIVERSITAT POLITECNICA DE VALENCIA, FUNDACION PARA LA INVESTIGACION MEDICA APLICADA, UNIVERSIDAD DE NAVARRA

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Comments

Other related patents

Health

BIOTECHNOLOGICAL PRODUCTION OF D-DIBOA AND ITS CHLORINATED DERIVATES FROM ITS NITROPHENOXIDE-ACETATE PRECURSORS

Countries

Spain

Health

Gelled microspheres for the vehicleization and release of therapeutic agents

Countries

Spain

Health

DEVICE FOR MEASURING INTRINSIC AUTOFLUORESCENCE OF A BIOLOGICAL SAMPLE AND METHOD USING THEREOF

Countries

Spain

Get back to patents directory